home / stock / awknf / awknf quote
Last: | $0.0905 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1 |
Close: | $0.0905 |
High: | $0.1 |
Low: | $0.0905 |
Volume: | 11,000 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0905 | $0.1 | $0.0905 | $0.1 | $0.0905 | 11,000 | 03-29-2024 |
$0.0905 | $0.1 | $0.0905 | $0.1 | $0.0905 | 11,000 | 03-28-2024 |
$0.0901 | $0.09 | $0.0901 | $0.0901 | $0.09 | 4,621 | 03-27-2024 |
$0.098 | $0.0955 | $0.098 | $0.098 | $0.0955 | 450 | 03-26-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 8,000 | 03-25-2024 |
$0.09 | $0.0955 | $0.09 | $0.11 | $0.09 | 2,812 | 03-22-2024 |
$0.0955 | $0.11 | $0.0955 | $0.11 | $0.0955 | 4,403 | 03-20-2024 |
$0.08928 | $0.095 | $0.08928 | $0.11 | $0.08928 | 37,050 | 03-19-2024 |
$0.1071 | $0.09 | $0.1071 | $0.1071 | $0.085 | 5,896 | 03-18-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 8,000 | 03-15-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 9,500 | 03-14-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 3,000 | 03-13-2024 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 9,600 | 03-12-2024 |
$0.1 | $0.096 | $0.1 | $0.103 | $0.096 | 1,810 | 03-11-2024 |
$0.09 | $0.098 | $0.09 | $0.098 | $0.09 | 491 | 03-08-2024 |
$0.1 | $0.09 | $0.1 | $0.1 | $0.09 | 3,164 | 03-07-2024 |
$0.11 | $0.12 | $0.11 | $0.12 | $0.09 | 14,200 | 03-06-2024 |
$0.09 | $0.0934 | $0.09 | $0.11 | $0.080367 | 48,571 | 03-05-2024 |
$0.0934 | $0.095 | $0.0934 | $0.095 | $0.0934 | 550 | 03-04-2024 |
$0.1 | $0.1199 | $0.1 | $0.1199 | $0.09995 | 5,700 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Awakn Life Sciences Company Name:
AWKNF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario--(Newsfile Corp. - Le 9 février/February 2024) - The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. Awakn Life Sciences Corp. is a clinic...
Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder ("AUD"), is pleased to...
Toronto, Ontario--(Newsfile Corp. - February 5, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder ("AUD"), is pleased to ...